Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk

por Hamada, Tsuyoshi, Yuan, Chen, Yurgelun, Matthew B., Perez, Kimberly, Khalaf, Natalia, Morales-Oyarvide, Vicente, Babic, Ana, Nowak, Jonathan A., Rubinson, Douglas A., Giannakis, Marios, Ng, Kimmie, Kraft, Peter, Stampfer, Meir J., Giovannucci, Edward L., Fuchs, Charles S., Ogino, Shuji, Wolpin, Brian M.
Publicado 2019

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherap...

por Oh, Hyeon Jeong, Bae, Jeong Mo, Wen, Xianyu, Jung, Seorin, Kim, Younghoon, Kim, Kyung Ju, Cho, Nam-Yun, Kim, Jung Ho, Han, Sae-Won, Kim, Tae-You, Kang, Gyeong Hoon
Publicado 2019

Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts

por Xu, Xiaowen, Zhu, Li, Yang, Yun, Pan, Yamin, Feng, Zhuo, Li, Ye, Chang, Wenjun, Sui, Jinke, Cao, Fuao
Publicado 2019

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

por Bonnefoi, Hervé, MacGrogan, Gaetan, Poncet, Coralie, Iggo, Richard, Pommeret, Fanny, Grellety, Thomas, Larsimont, Denis, Bécette, Véronique, Kerdraon, Olivier, Bibeau, Frédéric, Ghnassia, Jean-Pierre, Picquenot, Jean-Michel, Thomas, Jeremy, Tille, Jean-Christophe, Slaets, Leen, Bodmer, Alexandre, Bergh, Jonas, Cameron, David
Publicado 2019

Sorafenib alone vs. sorafenib plus GEMOX as 1(st)-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial

por Assenat, Eric, Pageaux, Georges-Philippe, Thézenas, Simon, Peron, Jean-Marie, Bécouarn, Yves, Seitz, Jean-François, Merle, Philippe, Blanc, Jean-Frédéric, Bouché, Olivier, Ramdani, Mohamed, Poujol, Sylvain, de Forges, Hélène, Ychou, Marc, Boige, Valérie
Publicado 2019

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

por Moon, Jai-Hee, Hong, Seung-Woo, Kim, Jeong Eun, Shin, Jae-Sik, Kim, Jin-Sun, Jung, Soo-A, Ha, Seung Hee, Lee, Seul, Kim, Joseph, Lee, Dae Hee, Park, Yoon Sun, Kim, Dong Min, Park, Sang-Soo, Hong, Jun Ki, Kim, Do Yeon, Kim, Eun Ho, Jung, Joonyee, Kim, Mi Jin, Kim, Seung-Mi, Deming, Dustin A., Kim, Kyunggon, Kim, Tae Won, Jin, Dong-Hoon
Publicado 2019

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

por Ribi, Karin, Luo, Weixiu, Colleoni, Marco, Karlsson, Per, Chirgwin, Jacquie, Aebi, Stefan, Jerusalem, Guy, Neven, Patrick, Di Lauro, Vincenzo, Gomez, Henry L., Ruhstaller, Thomas, Abdi, Ehtesham, Biganzoli, Laura, Müller, Bettina, Barbeaux, Annelore, Graas, Marie-Pascale, Rabaglio, Manuela, Francis, Prudence A., Foukakis, Theodoros, Pagani, Olivia, Graiff, Claudio, Vorobiof, Daniel, Maibach, Rudolf, Di Leo, Angelo, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Regan, Meredith M., Bernhard, Jürg
Publicado 2019

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

por Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster, Abenaa M., Barcenas, Carlos H., Brown, Powel H., Giordano, Sharon H., Moulder, Stacy L., Booser, Daniel J., Moscow, Jeffrey A., Piekarz, Richard, Valero, Vicente, Ueno, Naoto T.
Publicado 2019

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

por Auclin, Edouard, André, Thierry, Taieb, Julien, Banzi, Maria, Van Laethem, Jean-Luc, Tabernero, Josep, Hickish, Tamas, de Gramont, Aimery, Vernerey, Dewi
Publicado 2019

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

por Groen, Harry J. M., van der Heijden, Erik H. F. M., Klinkenberg, Theo J., Biesma, Bonne, Aerts, Joachim, Verhagen, Ad, Kloosterziel, Corinne, Pieterman, Remge, van den Borne, Ben, Smit, Hans J. M., Hoekstra, Otto, Schramel, Frans M. N. H., van der Noort, Vincent, van Tinteren, Harm, Smit, Egbert F., Dingemans, Anne-Marie C.
Publicado 2019

Poor outcome in hypoxic endometrial carcinoma is related to vascular density

por Reijnen, Casper, van Weelden, Willem Jan, Arts, Martijn S. J. P., Peters, Johan P., Rijken, Paul F., van de Vijver, Koen, Santacana, Maria, Bronsert, Peter, Bulten, Johan, Hirschfeld, Marc, Colas, Eva, Gil-Moreno, Antonio, Reques, Armando, Mancebo, Gemma, Krakstad, Camilla, Trovik, Jone, Haldorsen, Ingfrid S., Huvila, Jutta, Koskas, Martin, Weinberger, Vit, Minar, Lubos, Jandakova, Eva, Snijders, Marc P. L. M., van den Berg-van Erp, Saskia, Küsters-Vandevelde, Heidi V. N., Matias-Guiu, Xavier, Amant, Frederic, Massuger, Leon F. A. G., Bussink, Johan, Pijnenborg, Johanna M. A.
Publicado 2019

Physical activity during adolescence and risk of colorectal adenoma later in life: results from the Nurses’ Health Study II

por Rezende, Leandro Fórnias Machado de, Lee, Dong Hoon, Keum, NaNa, Nimptsch, Katharina, Song, Mingyang, Lee, I-Min, Eluf-Neto, José, Ogino, Shuji, Fuchs, Charles, Meyerhardt, Jeffrey, Chan, Andrew T., Willett, Walter, Giovannucci, Edward, Wu, Kana
Publicado 2019

Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer

por Yoneda, Kazue, Kuwata, Taiji, Kanayama, Masatoshi, Mori, Masataka, Kawanami, Toshinori, Yatera, Kazuhiro, Ohguri, Takayuki, Hisaoka, Masanori, Nakayama, Toshiyuki, Tanaka, Fumihiro
Publicado 2019

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial

por Veitch, Zachary W., Cescon, David W., Denny, Trisha, Yonemoto, Lisa-Maria, Fletcher, Graham, Brokx, Richard, Sampson, Peter, Li, Sze-Wan, Pugh, Trevor J., Bruce, Jeffrey, Bray, Mark R., Slamon, Dennis J., Mak, Tak W., Wainberg, Zev A., Bedard, Philippe L.
Publicado 2019

Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases

por Coati, Irene, Lotz, Gábor, Fanelli, Giuseppe Nicolò, Brignola, Stefano, Lanza, Cristiano, Cappellesso, Rocco, Pellino, Antonio, Pucciarelli, Salvatore, Spolverato, Gaya, Guzzardo, Vincenza, Munari, Giada, Zaninotto, Giovanni, Scarpa, Marco, Mastracci, Luca, Farinati, Fabio, Realdon, Stefano, Pilati, Pierluigi, Lonardi, Sara, Valeri, Nicola, Rugge, Massimo, Kiss, Andras, Loupakis, Fotios, Fassan, Matteo
Publicado 2019

The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia

por Visentin, Andrea, Bonaldi, Laura, Rigolin, Gian Matteo, Mauro, Francesca Romana, Martines, Annalisa, Frezzato, Federica, Imbergamo, Silvia, Scomazzon, Edoardo, Pravato, Stefano, Bardi, Maria Antonella, Cavallari, Maurizio, Volta, Eleonora, Cavazzini, Francesco, Nanni, Maurizio, Del Giudice, Ilaria, Facco, Monica, Guarini, Anna, Semenzato, Gianpietro, Foà, Robin, Cuneo, Antonio, Trentin, Livio
Publicado 2019

The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial

por Harvie, Michelle, Pegington, Mary, McMullan, Debbie, Bundred, Nigel, Livingstone, Karen, Campbell, Anna, Wolstenholme, Jane, Lovato, Eleanora, Campbell, Helen, Adams, Judith, Speed, Sean, Morris, Julie, Howell, Sacha, Howell, Anthony
Publicado 2019

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

por Metcalfe, Kelly, Eisen, Andrea, Senter, Leigha, Armel, Susan, Bordeleau, Louise, Meschino, Wendy S., Pal, Tuya, Lynch, Henry T., Tung, Nadine M., Kwong, Ava, Ainsworth, Peter, Karlan, Beth, Moller, Pal, Eng, Charis, Weitzel, Jeffrey N., Sun, Ping, Lubinski, Jan, Narod, Steven A.
Publicado 2019

Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase

por Jathal, Maitreyee K., Steele, Thomas M., Siddiqui, Salma, Mooso, Benjamin A., D’Abronzo, Leandro S., Drake, Christiana M., Whang, Young E., Ghosh, Paramita M.
Publicado 2019

Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracycli...

por Munzone, Elisabetta, Bagnardi, Vincenzo, Campennì, Giuseppe, Mazzocco, Ketti, Pagan, Eleonora, Tramacere, Andrea, Masiero, Marianna, Iorfida, Monica, Mazza, Manuelita, Montagna, Emilia, Cancello, Giuseppe, Bianco, Nadia, Palazzo, Antonella, Cardillo, Anna, Dellapasqua, Silvia, Sangalli, Claudia, Pettini, Greta, Pravettoni, Gabriella, Colleoni, Marco, Veronesi, Paolo
Publicado 2019